Works matching IS 10837159 AND DT 2024 AND VI 29 AND IP 11

Results: 36

Correction to: Systemic inflammation and changes in physical well-being in patients with breast cancer: a longitudinal study in community oncology settings.

Published in:: 2024
Publication type:: Correction Notice

Closing the gap: proposing a socio-ecological framework to make cancer clinical trials more accessible, equitable, and acceptable to adolescents and young adults.

Published in:

Oncologist, 2024, v. 29, n. 11, p. 918, doi. 10.1093/oncolo/oyae257

By:

Ahmad, Zeba;
Venkataraman, Vinayak;
Markwart, Michaela;
Abrams, Annah N;
Temel, Jennifer S;
Perez, Giselle K

Publication type:

Article

Correction to: Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study.

Published in:: 2024
Publication type:: Correction Notice

Highlights of ASCO 2024.

Published in:

2024

By:

Neugut, Alfred I;
Bates, Susan E

Publication type:

Proceeding

Characterization of driver mutations identifies gene signatures predictive of prognosis and treatment sensitivity in multiple myeloma.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1552, doi. 10.1093/oncolo/oyae244

By:

Li, Jian-Rong;
Parthasarathy, Abinand Krishna;
Kannappan, Aravind Singaram;
Arsang-Jang, Shahram;
Dong, Jing;
Cheng, Chao

Publication type:

Article

Meta-analysis of platinum chemotherapy combinations with immunotherapy in metastatic urothelial carcinoma.

Published in:

Oncologist, 2024, v. 29, n. 11, p. 999, doi. 10.1093/oncolo/oyae243

By:

Bolek, Hatice;
Yazgan, Satı Coskun;
Yekedüz, Emre;
Ürün, Yüksel

Publication type:

Article

Correction to: Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma.

Published in:: 2024
Publication type:: Correction Notice

Correction to: Prediction of moderate and severe toxicities of chemotherapy in older patients with cancer: a propensity weighted analysis of ELCAPA cohort.

Published in:: 2024
Publication type:: Correction Notice

Correction to: Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis.

Published in:: 2024
Publication type:: Correction Notice

Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study.

Published in:

Oncologist, 2024, v. 29, n. 11, p. 957, doi. 10.1093/oncolo/oyae210

By:

Borazanci, Erkut H;
Bahary, Nathan;
Chung, Vincent;
Huyck, Timothy K;
Kio, Ebenezer A;
Chiorean, Elena Gabriela;
Skeel, Roland T;
Alese, Olatunji B;
Cardin, Dana B;
Fountzilas, Christos;
Hanna, Wahid T;
Leal, Alexis D;
Lee, Valerie;
Noonan, Anne M;
Philip, Philip A;
Wainberg, Zev A;
Pashova, Hristina;
Mann, Grace;
Oberstein, Paul E

Publication type:

Article

Correction to: Enhanced stiffness in peri-cancerous tissue: a marker of poor prognosis in papillary thyroid carcinoma with lymph node metastasis.

Published in:: 2024
Publication type:: Correction Notice

Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma.

Published in:

Oncologist, 2024, v. 29, n. 11, p. 997, doi. 10.1093/oncolo/oyae207

By:

Li, Zhiwei;
Fan, Xiaona;
Jiang, Dan;
Li, Qingwei;
Liu, Chao;
Wang, Dan;
Li, Na;
Li, Hengzhen;
Chen, Zhuo;
Tang, Hongzhen;
Lou, Changjie;
Xu, Haitao;
Zhan, Chao;
Dong, Yuandi;
Ma, Zhigang;
Wang, Guangyu;
Zhang, Chunhui;
Lu, Haibo;
Zheng, Tongsen;
Zhang, Yanqiao

Publication type:

Article

Advances and future directions in ROS1 fusion-positive lung cancer.

Published in:

Oncologist, 2024, v. 29, n. 11, p. 943, doi. 10.1093/oncolo/oyae205

By:

Boulanger, Mary C;
Schneider, Jaime L;
Lin, Jessica J

Publication type:

Article

Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomes.

Published in:

Oncologist, 2024, v. 29, n. 11, p. 966, doi. 10.1093/oncolo/oyae202

By:

Wotman, Michael T;
Ivic-Pavlicic, Tara;
Westra, William H;
Gold, Brandon;
D'Andrea, Megan;
Genden, Eric M;
Misiukiewicz, Krzysztof;
Roof, Scott A;
Taioli, Emanuela;
Posner, Marshall

Publication type:

Article

The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1532, doi. 10.1093/oncolo/oyae201

By:

Steventon, Luke;
Man, Kenneth K C;
Nicum, Shibani;
Miller, Rowan E;
Peleg Hasson, Shira;
Shah, Samixa;
Baser, Michael;
Kipps, Emma;
Forster, Martin D;
Almossawi, Ofran;
Chambers, Pinkie

Publication type:

Article

Correction to: Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors.

Published in:: 2024
Publication type:: Correction Notice

Social supports in patients with cancer attending an Irish cancer center: a cross-sectional study.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1621, doi. 10.1093/oncolo/oyae196

By:

Goggin, Caitriona;
Ged, Yasser;
Bracken-Clarke, Dara;
Hannan, Michelle;
Calacsan, Flordeliza;
Jordan, Emmet;
Calvert, Paula M;
O'Connor, Miriam;
Horgan, Anne M

Publication type:

Article

Assessment of psycho-oncology in the Middle East and North Africa region: a systematic review and meta-analysis.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1452, doi. 10.1093/oncolo/oyae193

By:

Al-Hussaini, Maysa;
Abdel-Razeq, Hikmat;
Shamieh, Omar;
Al-Ani, Abdallah;
Hammouri, Muhammad;
Mansour, Asem

Publication type:

Article

Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapy.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1501, doi. 10.1093/oncolo/oyae190

By:

Wang, Xin;
Allen, Michael J;
Espin-Garcia, Osvaldo;
Suzuiki, Chihiro;
Bach, Yvonne;
Panov, Elan;
Ma, Lucy X;
Jang, Raymond W;
Chen, Eric X;
Darling, Gail E;
Yeung, Jonathan;
Swallow, Carol J;
Brar, Savtaj Singh;
Kalimuthu, Sangeetha;
Wong, Rebecca;
Veit-Haibach, Patrick;
Elimova, Elena

Publication type:

Article

Immune-related adverse events requiring hospitalization in patients with lung cancer: implications and insights.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1615, doi. 10.1093/oncolo/oyae189

By:

Falade, Ayo;
Zubiri, Leyre;
Wu, Chia-Yun;
Perlman, Katherine;
Sun, Joie;
Hathaway, Nora;
Grealish, Kelley;
Lopiccolo, Jackie;
Reynolds, Kerry;
Mooradian, Meghan J

Publication type:

Article

Patients' considerations of time toxicity when assessing cancer treatments with marginal benefit.

Published in:

Oncologist, 2024, v. 29, n. 11, p. 978, doi. 10.1093/oncolo/oyae187

By:

Gupta, Arjun;
Brundage, Michael D;
Galica, Jacqueline;
Karim, Safiya;
Koven, Rachel;
Ng, Terry L;
O'Donnell, Jennifer;
tenHove, Julia;
Robinson, Andrew;
Booth, Christopher M

Publication type:

Article

Ocular adverse events associated with antibody-drug conjugates for cancer: evidence and management strategies.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1435, doi. 10.1093/oncolo/oyae177

By:

Dy, Grace K;
Farooq, Asim V;
Kang, Joann J

Publication type:

Article

Efficacy of transdermal buprenorphine patch for managing withdrawal symptoms in patients with cancer physically dependent on prescription opioids.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1593, doi. 10.1093/oncolo/oyae176

By:

Kang, Jung Hun;
Lee, Kyung Hee;
Huh, Seok Jae;
Shin, Seong-Hoon;
Kim, Il Hwan;
Hwang, In Gyu;
Koo, Dong-Hoe;
Lee, Dongyun;
Koh, Su-Jin;
Seo, Seyoung;
Lee, Guk Jin;
Chun, Sang Hoon;
Ji, Jun Ho;
Oh, Sung Yong;
Choi, Jung Woo;
Go, Se-Il

Publication type:

Article

Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1480, doi. 10.1093/oncolo/oyae168

By:

Morgenstern-Kaplan, Dan;
Kareff, Samuel A;
Trabolsi, Asaad;
Rodriguez, Estelamari;
Krause, Harris;
Ribeiro, Jennifer R;
Tan, Heng;
Antonarakis, Emmanuel S;
Lou, Emil;
Nagasaka, Misako;
Algaze, Sandra;
Lenz, Heinz-Josef;
Liu, Stephen V;
Halmos, Balazs;
Hoon, Dave S B;
Seeber, Andreas;
Ma, Patrick C;
El-Deiry, Wafik S;
Vanderwalde, Ari M;
Lopes, Gilberto

Publication type:

Article

Patient-reported convenience and effectiveness of telehealth for breast cancer management.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1470, doi. 10.1093/oncolo/oyae165

By:

Raghavendra, Akshara Singareeka;
Jennings, Kristofer;
Guerra, Gil;
Tripathy, Debu;
Karuturi, Meghan S

Publication type:

Article

Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1511, doi. 10.1093/oncolo/oyae160

By:

Pichler, Renate;
Fritz, Josef;
Mari, Andrea;
Cadenar, Anna;
Deimling, Markus von;
Marcq, Gautier;
Giudice, Francesco del;
Leonardo, Costantino;
Bologna, Eugenio;
Mori, Keiichiro;
Tahbaz, Rana;
Santis, Maria De;
Klatte, Tobias;
Erber, Barbara;
Lackner, Felizian;
Kronbichler, Andreas;
Seeber, Andreas;
Fisch, Margit;
Moschini, Marco;
Pradere, Benjamin

Publication type:

Article

Current status of advance care planning, palliative care consultation, and end-of-life care in patients with glioblastoma in South Korea.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1586, doi. 10.1093/oncolo/oyae159

By:

Suh, Koung Jin;
Jung, Eun Hee;
Seo, Jeongmin;
Ji, So Young;
Hwang, Kihwan;
Han, Jung Ho;
Kim, Chae-Yong;
Kim, In Ah;
Kim, Yu Jung

Publication type:

Article

Prediction of moderate and severe toxicities of chemotherapy in older patients with cancer: a propensity weighted analysis of ELCAPA cohort.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1523, doi. 10.1093/oncolo/oyae157

By:

Benderra, Marc-Antoine;
Paillaud, Elena;
Broussier, Amaury;
Layese, Richard;
Tapia, Claudia M;
Mebarki, Soraya;
Boudou-Rouquette, Pascale;
Laurent, Marie;
Piero, Monica;
Rollot-Trad, Florence;
Gligorov, Joseph;
Caillet, Philippe;
Canoui-Poitrïne, Florence

Publication type:

Article

Efficacy and safety of camrelizumab, apatinib, and capecitabine combination therapy in advanced biliary tract cancer: a phase 2, nonrandomized, prospective study.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1565, doi. 10.1093/oncolo/oyae154

By:

Jing, Chao;
Bai, Zhigang;
Tong, Kuinan;
Yang, Xiaobao;
Liu, Kun;
Wu, Hongwei;
Zhu, Jiegao;
Guo, Wei;
Zhang, Zhongtao;
Deng, Wei

Publication type:

Article

National survey of patient perspectives on cost discussions among recipients of copay assistance.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1540, doi. 10.1093/oncolo/oyae148

By:

Lam, Anh B;
Nipp, Ryan David;
Hasler, Jill S;
Hu, Bonnie Y;
Zahner, Greg J;
Robbins, Sarina;
Wheeler, Stephanie B;
Tagai, Erin K;
Miller, Suzanne M;
Peppercorn, Jeffrey M

Publication type:

Article

Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy.

Published in:

Oncologist, 2024, v. 29, n. 11, p. 922, doi. 10.1093/oncolo/oyae089

By:

Smith-Uffen, Megan;
Park, John;
Parsonson, Andrew;
Kiely, Belinda E;
Vasista, Anuradha

Publication type:

Article

Investigating risk factors and treatment options for severe, partially steroid responsive, and steroid-refractory checkpoint inhibitor pneumonitis.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1575, doi. 10.1093/oncolo/oyae147

By:

Moodabagil, Meghana;
Easterling, Robert;
Peng, Jing;
Abu-Sbeih, Hamzah;
Meara, Alexa;
Donnelly, Edwin;
Owen, Dwight H;
Ho, Kevin

Publication type:

Article

A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trial.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1492, doi. 10.1093/oncolo/oyae140

By:

Samaille, Thomas;
Falcoz, Antoine;
Cohen, Romain;
Laurent-Puig, Pierre;
André, Thierry;
Taieb, Julien;
Auclin, Edouard;
Vernerey, Dewi

Publication type:

Article

Opioid metabolism and drug-drug interaction in cancer.

Published in:

Oncologist, 2024, v. 29, n. 11, p. 931, doi. 10.1093/oncolo/oyae094

By:

Aapro, Matti;
Fogli, Stefano;
Morlion, Bart;
Danesi, Romano

Publication type:

Article

Atezolizumab plus bevacizumab as first-line systemic therapy for hepatocellular carcinoma: a multi-institutional cohort study.

Published in:

Oncologist, 2024, v. 29, n. 11, p. 986, doi. 10.1093/oncolo/oyae142

By:

Storandt, Michael H;
Zemla, Tyler J;
Patell, Kanchi;
Naleid, Nikolas;
Gile, Jennifer J;
Tran, Nguyen H;
Chakrabarti, Sakti;
Jin, Zhaohui;
Borad, Mitesh;
Mahipal, Amit

Publication type:

Article

Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis.

Published in:

Oncologist, 2024, v. 29, n. 11, p. e1425, doi. 10.1093/oncolo/oyae134

By:

Liu, Shi-Jia;
Yan, Lun-Jie;
Wang, Han-Chao;
Ding, Zi-Niu;
Liu, Hui;
Zhang, Xiao;
Pan, Guo-Qiang;
Han, Cheng-Long;
Tian, Bao-Wen;
Yang, Xiao-Rong;
Tan, Si-Yu;
Dong, Zhao-Ru;
Wang, Dong-Xu;
Yan, Yu-Chuan;
Li, Tao

Publication type:

Article